20909 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Depsipeptides; Derivatives thereof
Aplidine for multiple myeloma treatment
#302Histone deacetylase inhibitors for treating degenerative diseases of the eye
#303MODULATION OF NEUORGENESIS BY HDac INHIBITION
#304Endoparasiticidal compositions for topical application
#305Pharmaceutical compositions of (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
#306Lipopeptide stereoisomers, methods for preparing same and useful intermediates
#307Novel depsipeptides and process for preparing same
#308Antitumoral treatments
#309Aplidine for multiple myeloma treatment
#310Depsipeptide for therapy of kidney cancer
#311Histone deacetylase inhibitors and methods of use
#312Method for diagnosing and treating NIS-expressing carcinomas and metastases
#313Combination of a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]2-methylphenyl}-4- (3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia
#314SNS-595 and methods of using the same
#315SNS-595 and methods of using the same
#316Histone deacetylase inhibitors and cognitive applications
#317Method of treating TRX mediated diseases
#318Method of treating TRX mediated diseases
#319Arthrodial cartilage extracellular matrix degradation inhibitor
#320Method for reducing radiation-induced normal tissue damage
#321Prevention of joint destruction
#322Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
#323Methods for treating or preventing GVHD
#324Methods of using SNS-595
#325Resorbable polymeric device for localized drug delivery
#326Biodegradable bio-absorbable material for clinical practice and method for producing the same
#327Device for regeneration of articular cartilage and other tissue
#328Composition and method for treating neurological disorders
#329Use of aplidine for the treatment of pancreatic cancer
#330Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
#331Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
#332Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
#333Pristinamycin compositions, LPXC compositions, their improvements, and combinations thereof
#334Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof